ARS Pharmaceuticals Inc
(NAS:SPRY)
$
11.66
0.31 (2.73%)
Market Cap: 1.13 Bil
Enterprise Value: 875.38 Mil
PE Ratio: 0
PB Ratio: 5.03
GF Score: 19/100 ARS Pharmaceuticals Inc (SPRY) Transcripts
- ARS Pharmaceuticals Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 16, 2023
- Silverback Therapeutics Inc and ARS Pharmaceuticals Inc Merger Announcement Call TranscriptJul 21, 2022
- Silverback Therapeutics Inc Strategic Prioritization and Corporate Update Call TranscriptMar 31, 2022
- Silverback Therapeutics Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 16, 2022
- Silverback Therapeutics Inc at H C Wainwright Bioconnect Conference (Virtual) TranscriptJan 10, 2022
- Silverback Therapeutics Inc SBT6050 Clinical Data Update Call TranscriptSep 16, 2021
- 1